severe asthma

Severe asthma outcomes over two years of therapy with mepolizumab
Lynn Elsey, Thomas Pantin, Leanne J Holmes, Gael Tavernier, Stephen J Fowler

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3737; DOI: 10.1183/13993003.congress-2021.PA3737
Real-World Experience with dupilumab in Severe Asthma: One year data from an Italian Named Patient Program
Santi Nolasco, Raffaele Campisi, Claudia Crimi, Nicola Scichilone, Morena Porto, Gabriella Guarnieri, Alberto Papi, Bianca Beghé, Pietro Impellizzeri, Nunzio Crimi

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3743; DOI: 10.1183/13993003.congress-2021.PA3743
Monoclonal antibody treatments for paediatric severe asthma–outcomes, attitudes and adherence
Megan Sheppard, Ajay Kevat, Louisa Owens, Melinda Gray

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3931; DOI: 10.1183/13993003.congress-2021.PA3931
Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes
Wei Chern Gavin Fong, Adnan Azim, Deborah Knight, Heena Mistry, Anna Freeman, Mae Felongco, Aref Kyyaly, Matthew Harvey, Paddy Dennison, Hongmei Zhang, Peter Howarth, Syed Hasan Arshad, Ramesh Kurukulaaratchy

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3740; DOI: 10.1183/13993003.congress-2021.PA3740
Late Breaking Abstract - Phase 2 trial evaluating the effects of dexpramipexole on blood eosinophils, lung function, and airway biomarkers in eosinophilic asthma
Salman Siddiqui, Michael Bozik, Donald Archibald, Steven Dworetzky, James Mather, Randall Killingsworth, Sergei Ochkur, Elizabeth Jacobsen, Reynold Panettieri, Calman Prussin

European Respiratory Journal Sep 2021, 58 (suppl 65) RCT2900; DOI: 10.1183/13993003.congress-2021.RCT2900
Characteristics of a real world cohort of Canadians treated with benralizumab
Stephen G Noorduyn, Mackenzie A Hamilton, Brett Lancaster, Alain Gendron, Lawrence Mbuagbaw, Erika Penz

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3726; DOI: 10.1183/13993003.congress-2021.PA3726
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients
Sabina Škrgat, Maruša Kopač, Matija Rijavec, Uška Bidovec Stojković, Izidor Kern, Romana Vantur, Peter Korošec

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3730; DOI: 10.1183/13993003.congress-2021.PA3730
Spanish consensus on the characteristics of severe asthmatic patients under biological treatment suitable for at home administration
Ana Gomez-Bastero Fernandez, Eusebi Chiner, Carolina Cisneros Serrano, Juan Manuel Igea, Elena Villamañán Bueno, Manuel Jorge Rial, Maria José Pla Martí, Valentín López Carrasco, Ana Martínez Meca, Luis Carlos Fernández Lisón, Mª Guadalupe Sánchez-Herrero, Beatriz Velasco-Laorga

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3728; DOI: 10.1183/13993003.congress-2021.PA3728
Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma
Lawrence Sher, Giovanni Passalacqua, Camille Taillé, Lauren Cohn, Santiago Quirce, Nadia Daizadeh, Nami Pandit-Abid, Benjamin Ortiz, Asif H. Khan, Yi Zhang

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3733; DOI: 10.1183/13993003.congress-2021.PA3733
The effect of CPAP in asthma patients with SAHS
Gorane Iturricastillo, Elisa Martínez, José María Eiros, Pedro Landete, Elena Ávalos, Carolina Cisneros, Julio Ancochea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3579; DOI: 10.1183/13993003.congress-2021.PA3579

Main menu

User menu

Search

severe asthma

Pages

Contact us